Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 10(7): e0134349, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26222318

RESUMO

BACKGROUND: Abdominal bloating is a common and bothersome symptom of chronic idiopathic constipation. The objective of this trial was to evaluate the efficacy and safety of linaclotide in patients with chronic idiopathic constipation and concomitant moderate-to-severe abdominal bloating. METHODS: This Phase 3b, randomized, double-blind, placebo-controlled clinical trial randomized patients to oral linaclotide (145 or 290 µg) or placebo once daily for 12 weeks. Eligible patients met Rome II criteria for chronic constipation upon entry with an average abdominal bloating score ≥5 (self-assessment: 0 10-point numerical rating scale) during the 14-day baseline period. Patients reported abdominal symptoms (including bloating) and bowel symptoms daily; adverse events were monitored. The primary responder endpoint required patients to have ≥3 complete spontaneous bowel movements/week with an increase of ≥1 from baseline, for ≥9 of 12 weeks. The primary endpoint compared linaclotide 145 µg vs. placebo. RESULTS: The intent-to-treat population included 483 patients (mean age=47.3 years, female=91.5%, white=67.7%). The primary endpoint was met by 15.7% of linaclotide 145 µg patients vs. 7.6% of placebo patients (P<0.05). Both linaclotide doses significantly improved abdominal bloating vs. placebo (P<0.05 for all secondary endpoints, controlling for multiplicity). Approximately one-third of linaclotide patients (each group) had ≥50% mean decrease from baseline in abdominal bloating vs. 18% of placebo patients (P<0.01). Diarrhea was reported in 6% and 17% of linaclotide 145 and 290 µg patients, respectively, and 2% of placebo patients. AEs resulted in premature discontinuation of 5% and 9% of linaclotide 145 µg and 290 µg patients, respectively, and 6% of placebo patients. CONCLUSIONS: Once-daily linaclotide (145 and 290 µg) significantly improved bowel and abdominal symptoms in chronic idiopathic constipation patients with moderate-to-severe baseline abdominal bloating; in particular, linaclotide significantly improved abdominal bloating compared to placebo, an important finding given the lack of agents available to treat abdominal bloating in chronic idiopathic constipation patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT01642914.


Assuntos
Constipação Intestinal/tratamento farmacológico , Fármacos Gastrointestinais/uso terapêutico , Peptídeos/uso terapêutico , Dor Abdominal/tratamento farmacológico , Dor Abdominal/fisiopatologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença Crônica , Constipação Intestinal/fisiopatologia , Método Duplo-Cego , Feminino , Fármacos Gastrointestinais/administração & dosagem , Fármacos Gastrointestinais/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Peptídeos/administração & dosagem , Peptídeos/efeitos adversos , Resultado do Tratamento , Adulto Jovem
2.
J Environ Sci (China) ; 19(4): 488-93, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17915714

RESUMO

Based on hydrology, temperature, and precipitation data from the past 50 years, the effects of climate change on water resources in Tarim River Basin in Northwest China were investigated. The long-term trends of the hydrological time series were detected using both parametric and nonparametric techniques. The results showed that the increasing tendency of the temperature has a 5% level of significance, and the temperature increased by nearly 1 degree C over the past 50 years. The precipitation showed a significant increase in the 1980s and 1990s, and the average annual precipitation exhibited an increasing trend with a magnitude of 6.8 mm per decade. A step change occurred in both the temperature and precipitation time series around 1986. The streamflow from the headwater of the Tarim River exhibited a significant increase during the last 20 years. The increase in temperature, precipitation, and streamflow may be attributed to global climate change.


Assuntos
Clima , Rios , China , Chuva , Temperatura , Movimentos da Água
3.
Cell Stress Chaperones ; 12(4): 364-72, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18229455

RESUMO

Heat shock proteins are induced under stress conditions and they act as molecular chaperones to refold denatured polypeptides. Stress resistances including thermotolerance generally are correlated with levels of the heat shock proteins. We investigated a fruit fly gene encoding a small heat shock protein, Hsp27, to determine if it functions in stress response of Drosophila melanogaster. A knockout Hsp27 allele was generated. Flies homozygous for this allele were viable, without obvious defects, and fertile, indicating Hsp27 is not essential for development. In stress-response tests, loss of the Hsp27 gene caused no defects in resistance to heat shock or oxidative treatments. However, a significant reduction in starvation resistance was associated with the genotype without a functional Hsp27 gene. The data suggest that the Drosophila HSP27 protein acts as a chaperone to provide cellular stress resistance, although its function may be limited to a subset of the stress response such as the starvation resistance.


Assuntos
Drosophila melanogaster/crescimento & desenvolvimento , Privação de Alimentos , Proteínas de Choque Térmico/genética , Alelos , Animais , Sequência de Bases , Drosophila melanogaster/efeitos dos fármacos , Proteínas de Choque Térmico/metabolismo , Resposta ao Choque Térmico/efeitos dos fármacos , Longevidade/efeitos dos fármacos , Masculino , Dados de Sequência Molecular , Óvulo/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Paraquat/farmacologia , Transcrição Gênica/efeitos dos fármacos
4.
Schizophr Res ; 73(2-3): 275-80, 2005 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-15653272

RESUMO

Recently the expression of human myelin/oligodendrocyte glycoprotein (MOG) has been found to be significantly downregulated in the brain tissue of subjects with schizophrenia, suggesting that the MOG gene resides within a high-susceptibility locus for schizophrenia. In order to test this prediction, we analyzed three microsatellites from MOG in the Han Chinese population using a sample of 532 trios. Analysis of allele, genotype and haplotype frequencies showed weak positive association between the markers and the disease (p=0.01982). Our results would indicate that the MOG gene may play a significant role in schizophrenia in the Han Chinese. However, further study is required using other methods and involving other populations.


Assuntos
Povo Asiático/genética , Glicoproteína Associada a Mielina/genética , Esquizofrenia/etnologia , Esquizofrenia/genética , China , Mapeamento Cromossômico , Primers do DNA/genética , Predisposição Genética para Doença , Haplótipos/genética , Humanos , Desequilíbrio de Ligação , Repetições de Microssatélites/genética , Proteínas da Mielina , Glicoproteína Mielina-Oligodendrócito
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...